PT

Dados B3 › VVEO3

VVEO3 (CM Hospitalar): has profit grown?

VVEO3 (CM Hospitalar): in 2025, net income attributable to controlling shareholders was R$ 18.2 million, down 95% versus 2023 (a profit of R$ 359.9 million); five years earlier (2020), a profit of R$ 121.8 million.

YearProfit (loss)Change
2025R$ 18.2 milliondown 95%
2023R$ 359.9 millionup 39%
2022R$ 259.7 milliondown 34%
2021R$ 395.2 millionup 225%
2020R$ 121.8 million—

Annual statements (DFP). Profit attributable to controlling shareholders when the company reports it; otherwise total net income. Fact with its source; not investment advice.

Check it yourself

Dividends · Debt · Full page · How much it returned · plain text for AI

Numbers on this page are live. Data version 2026-10-01-cfo-metodo-direto · page generated 2026-10-17 16:11 UTC. If this does not match /saude, you are reading a cached copy.

Sources: CVM (open data, ODbL) and B3 (COTAHIST). Not affiliated with B3 or the CVM. Not investment advice.

Numbers on this page are live. Data version 2026-10-01-cfo-metodo-direto · page generated 2026-10-17 16:11 UTC. If this does not match /saude, you are reading a cached copy.

Every Monday, what changed on B3: the week's facts on companies, REITs and ETFs, each with its number and the link to check it. Free; leave in one click. (E-mail in Portuguese.)